Parkinson’s disease (PD) is a progressive neurodegenerative disorder that is characterized by the loss of dopaminergic neurons in the substantia nigra of the brain and, in some cases, by the presence of Lewy bodies or abnormal deposits of the alpha-synuclein protein [1]. Here, SNCA is linked to Parkinson disease.